Monday, May 22, 2017 11:04:59 PM
Estimating 3,000 units now, huh.. but yeah, with the bills piling up, I bet you're pretty damn close. And they have that debt scattered all over the place as well. Be nice if they could consolidate it.
We're just going to have to watch and wait... see if this Lopez guy is going to be an asset... hoping he went to them because he wants them to be successful and sees opportunity, he seems to have a good chunk of change vested in his B&D franchises already so he has a reason to take the position. He definitely has the experience... let's just hope Wainer listens to the guy.
The ideal scenario is get someone with solid public company experience to take on a preferred placement for a few million bucks and a seat on the board... wishful thinking right??
If they can keep spending down and units from being recalled, no doubt they'll get there... but I'm not anticipating any surge in the pps at all anytime soon, next Q isn't due until August, time to just accumulate shares imo. Actually waiting on that hard dip, hate to say it but it's well over due... or maybe I'm just wishful thinking for a few more really cheap shares...
I'm a non-professional individual investor who may own, not own, buy, or sell stock at any given time in any security ever mentioned in posts. I never accept compensation in any form to post. Always consult an investment professional when investing.
Recent LTES News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/06/2024 11:49:48 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 01:07:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/28/2023 12:47:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 12:13:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/06/2023 06:06:55 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 11:37:34 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM